Su, S-H <br/><br/>
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling.  [electronic resource] 

 -  Neuroscience  Aug 2015 
 - 563-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7544 
<br/><br/><label>Standard No.: </label>10.1016/j.neuroscience.2015.03.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Benzamides--therapeutic use<br/>Benzoxazines--therapeutic use<br/>Calcium Channel Blockers--therapeutic use<br/>Carbamates--therapeutic use<br/>Carotid Stenosis--drug therapy<br/>Cerebral Cortex--pathology<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Enzyme Inhibitors--therapeutic use<br/>JNK Mitogen-Activated Protein Kinases--metabolism<br/>Male<br/>Maze Learning--drug effects<br/>Morpholines--therapeutic use<br/>Naphthalenes--therapeutic use<br/>Neurons--drug effects<br/>Phosphopyruvate Hydratase--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Signal Transduction--drug effects<br/>Time Factors